Status
Conditions
About
The purpose of this study is to develop and field-test new tools for diagnosis and hazard assessment of cardiometabolic risk (CMR) in people with chronic spinal cord injury (SCI) and to advance the evidence base with much needed information on CMR and cardiovascular disease (CVD) burden in people with SCI. These data can be used to develop screening guidelines for early identification and prevention of CMR in SCI, as well as targeted approaches to primary disease management.
Full description
Unlike current assessments utilizing lipid scores, the new system will be anchored in more reliable measurements of cardiovascular disease (CVD) burden using contemporary surrogate end points of coronary artery calcium (CAC) score, coronary CT angiography and carotid intima media thickness (CIMT). By the end of the 5-year funding cycle we will develop an updatable web-based cardiometabolic risk assessment tool (RISK) that will allow clinicians and SCI consumers to quantify risk for a cardiovascular sentinel event (stroke, non-fatal heart attack, or death) and will also provide a body mass index (BMI) table adjusted for SCI.
Specific Aims:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
traumatic spinal cord injury between C4 and T12
have a motor complete injury as classified as American Spinal Injury Association Impairment Scale (AIS) grade A or B
injury for more than 1 year
no known history of traumatic brain injury, cardiovascular disease or diabetes
not currently taking any medications to treat cardiovascular disease or diabetes
have multiple (i.e., 2+) of the following cardiometabolic risk factors:
Exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal